Mitochondrial disorders: Clinical and genetic features

Annual Review of Medicine

Volumn 50, Issue , 1999, Pages 111-127

  Simon, D K ^a   Johns, D R ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Mitochondria; Mitochondrial DNA; Mutation; Oxidative phosphorylation

Indexed keywords

MITOCHONDRIAL DNA;

AGING; CARDIOMYOPATHY; CELL ENERGY; CLINICAL FEATURE; DIABETES MELLITUS; DISORDERS OF MITOCHONDRIAL FUNCTIONS; GENE MUTATION; GENETIC COUNSELING; GENETICS; HUMAN; MITOCHONDRIAL RESPIRATION; MYOPATHY; NEUROPATHY; OPTIC NERVE ATROPHY; OXIDATIVE PHOSPHORYLATION; PARKINSON DISEASE; PERCEPTION DEAFNESS; PRIORITY JOURNAL; REVIEW; SEIZURE; STROKE;

AGING; CARDIOMYOPATHIES; CEREBROVASCULAR DISORDERS; DIABETES MELLITUS; DNA, MITOCHONDRIAL; GENETIC COUNSELING; GENETIC TECHNIQUES; HEARING LOSS, SENSORINEURAL; HUMANS; MITOCHONDRIA; MITOCHONDRIAL ENCEPHALOMYOPATHIES; MITOCHONDRIAL MYOPATHIES; MUTATION; NEURODEGENERATIVE DISEASES; OPTIC ATROPHIES, HEREDITARY; OXIDATIVE PHOSPHORYLATION; PARKINSON DISEASE; SEIZURES;

EID: 0032980279     PISSN: 00664219     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.med.50.1.111     Document Type: Review

References (96)

1. 1. Margulis L. 1970. Origin of Eukaryotic Cells. New Haven, CT: Yale Univ. Press
2. 2. Nass S, Naas MMK. 1963. Intramitochondrial fibers with DNA characteristics. J. Cell Biol. 19:613-29
3. 3. Shatz G, Haslbrunner E, Tuppy H. 1964. Deoxyribonucleic acid associated with yeast mitochondria. Biochem. Biophys. Res. Commun. 15:127-32
4. 4. Anderson S, Bankier AT, Barrell BG, et al. 1981. Sequence and organization of the human mitochondrial genome. Nature 290:457-65
5. 5. Ivanov PL, Wadhams MJ, Roby RK, et al. 1996. Mitochondrial DNA sequence heteroplasmy in the Grand Duke of Russia Georgij Romanow establishes the authenticity of the remains of Tsar Nicholas II. Nat. Genet.. 12:417-20
6. 6. Zeviani M, Servidei S, Gellera C, et al. 1989. An autosomal dominant disorder with multiple deletions of mitochondrial DNA starting at the D-loop region. Nature 339:309-11
7. 7. Carrozzo R, Hirano M, Fromenty B, et al. 1998. Multiple mtDNA deletions features in autosomal dominant and recessive diseases suggest distinct pathogenesis. Neurology 50:99-106
8. 8. Wallace DC, Singh G, Lott MT, et al. 1988. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science 242:1427-30
9. 9. Holt IJ, Harding AE, Morgan-Hughes JA. 1988. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature 331:717-19
10. 10. Lestienne P, Ponsot G. 1988. Kearnes-Sayre syndrome with muscle mitochondrial DNA deletion. Lancet 1:885
11. 11. Zeviani M, Morales CT, DiMauro S, et al. 1988. Deletions of mitochondrial DNA in Kearns-Sayre syndrome. Neurology 38: 1339-46
12. 12. Poulton J, Deadman ME, Gardiner RM. 1989. Duplications of mitochondrial DNA in mitochondrial myopathy. Lancet 1:236-40
13. 13. Luft R. 1994. The development of mitochondrial medicine. Proc. Natl. Acad. Sci. USA 91:8731-38
14. 14. Johns DR. 1995. Mitochondrial DNA and disease. N. Engl. J. Med. 333: 638-44
15. 15. Wallace DC. 1992. Mitochondrial genetics: a paradigm for aging and degenerative diseases? Science 256:628-32
16. 16. Johns DR. 1994. Genotype-specific phenotypes in Leber hereditary optic neuropathy. Clin. Neurosci. 2:146-50
17. 17. Savontaus ML. 1995. MtDNA mutations in Leber's hereditary optic neuropathy. Biochim. Biophys. Acta 1271:261-63
18. 18. Johns DR, Berman J. 1991. Alternative, simultaneous mutations in Leber's hereditary optic neuropathy. Biochem. Biophys. Res. Commun. 174:1324-30
19. 19. Brown MD, Sun F, Wallace DC. 1997. Clustering of Caucasian Leber hereditary optic neuropathy patients containing the 11778 or 14484 mutations on an mtDNA lineage. Am. J. Hum. Genet. 60:381-87
20. 20. Vilkki J, Ott J, Savontaus ML, et al. 1991. Optic atrophy in Leber hereditary optic neuropathy is probably determined by an X-chromosomal gene closely linked to DXS7. Am. J. Hum. Genet. 48:486-91
21. 21. Johns DR, Smith KH, Miller NR, et al. 1993. Identical twins who are discordant for Leber's hereditary optic neuropathy. Arch. Ophthalmol. 111:1491-94
22. 22. Cullom ME, Heher KL, Mille NR, et al. 1993. Leber's hereditary optic neuropathy masquerading as tobacco-alcohol amblyopia. Arch. Ophthalmol. 111: 1482-85
23. 23. Pavlakis SG, Phillips PC, DiMauro S, et al. 1984. Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes: a distinctive clinical syndrome. Ann. Neurol. 16:481-88
24. 24. Silvestri G, Ciafaloni E, Santorelli FM, et al. 1993. Clinical features associated with the A - G transition at nucleotide 8344 of mtDNA ("MERRF mutation"). Neurology 43:1200-6
25. 25. Silvestri G, Moraes CT, Shanske S, et al. 1992. A new mtDNA mutation in the rRNA(Lys) gene associated with myoclonic epilepsy and ragged-red fibers (MERRF). Am. J. Hum. Genet. 51: 1213-17
26. 26. Ozawa M, Nishino I, Horai S, et al. 1997. Myoclonus epilepsy associated with ragged-red fibers: a G-to-A mutation at nucleotide pair 8363 in mitochondrial tRNA(Lys) in two families. Muscle Nerve 20:271-78
27. 27. Zeviani M, Muntoni F, Savarese N, et al. 1993. A MERRF/MELAS overlap syndrome associated with a new point mutation in the mitochondrial DNA tRNA (Lys) gene. Eur. J. Hum. Genet. 1:80-87
28. 28. Moraes CT, Ciacci F, Bonilla E, et al. 1993. Two novel pathogenic mitochondrial DNA mutations affecting organelle number and protein synthesis. Is the tRNA(Leu(UUR)) gene an etiologic hot spot? J. Clin, Invest 92:2906-15
29. 29. Folgero T, Torbergsen T, Oian P, Folger T. 1995. The 3243 MELAS mutation in a pedigree with MERRF. Eur. Neurol. 35: 168-71
30. 30. Nakamura M, Nakano S, Goto Y, et al. 1995. A novel point mutation in the mitochondrial tRNA(Ser(UCN)) gene detected in a family with MERRF/MELAS overlap syndrome. Biochem. Biophys. Res. Commun. 214:86-93
31. 31. DiMauro S, Moraes CT. 1993. Mitochondrial encephalomyopathies. Arch. Neurol. 50:1197-208
32. 32. Moraes CT, Ciacci F, Silvestri G, et al. 1993. Atypical clinical presentations associated with the MELAS mutation at position 3243 of human mitochondrial DNA. Neuromuscul. Disord. 3:43-50
33. 33. Schon EA, Rizzuto R, Moraes CT, et al. 1989. A direct repeat is a hotspot for large-scale deletion of human mitochondrial DNA. Science 244:346-49
34. 34. Poulton J. 1992. Duplications of mitochondrial DNA: implications for pathogenesis. J. Inherit. Metab. Dis. 15:487-98
35. 35. Holt IJ, Harding AE, Petty RKH, Morgan-Hughes JA. 1990. A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am. J. Hum. Genet. 46:428-33
36. 36. Santorelli FM, Shanske S, Macaya A, et al. 1993. The mutation at nt 8993 of mitochondrial DNA is a common cause of Leigh's syndrome. Ann. Neurol. 34: 827-34
37. 37. De Meirleir L, Seneca S, Lissens W, et al. 1995. Bilateral striatal necrosis with a novel point mutation in the mitochondrial ATPase 6 gene. Pediatr. Neurol. 13: 242-46
38. 38. Thyagarajan D, Shanske S, Vasquez-Memije M, et al. 1995. A novel mitochondrial ATPase 6 point mutation in familial bilateral striatal necrosis. Ann. Neurol. 38:468-72
39. 39. Reid FM, Vernham GA, Jacobs HT. 1994. A novel mitochondrial point mutation in a maternal pedigree with sensorineural deafness. Hum. Mutat. 3:243-47
40. 40. Tiranti V, Chariot P, Carella F, et al. 1995. Maternally inherited hearing loss, ataxia and myoclonus associated with a novel point mutation in mitochondrial tRNA Ser(UCN) gene. Hum. Molec. Genet. 4:1421-27
41. 41. Santorelli FM, Mak S-C, El-Schahawi M, et al. 1996. Maternally inherited cardiomyopathy and hearing loss associated with a novel point mutation in the mitochondrial tRNA(Lys) gene (G8363A). Am. J. Hum. Genet. 58:933-39
42. 42. Prezant TR, Agapian JV, Bohlman MC, et al. 1993. Mitochondial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness. Nat. Genet. 4:289-94
43. 43. Hutchin T, Haworth I, Higashi K, et al. 1993. A molecular basis for human hypersensitivity to aminoglycoside antibiotics. Nucl. Acids Res. 21:4174-79
44. 44. Inoue K, Takai D, Soejima A, et al. 1996. Mutant mtDNA at 1555 A to G in 12S rRNA gene and hypersusceptibility of mitochondrial translation to streptomycin can be cotransferred to rho 0 HeLa cells. Biochem. Biophys. Res. Commun. 223: 496-501
45. 45. Pearson HA, Lobel JS, Kocoshis SA, et al. 1979. A new syndrome of refractory sideroblastic anemia with vacuolization of marrow precursors and exocrine pancreatic dysfunction. J. Pediatr. 95: 976-84
46. 46. Rotig A, Colonna M, Bonnefont JP, et al. 1989. Mitochondrial DNA deletion in Pearson's marrow/pancreas syndrome. Lancet 1 :902-3
47. 47. McShane MA, Hammans SR, Sweeney M, et al. 1991. Pearson syndrome and mitochondrial encephalomyopathy in a patient with a deletion of mitochondrial DNA. Am. J. Hum. Genet. 48:39-42
48. 48. Onishi H, Inoue K, Osaka H, et al. 1993. Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) and diabetes mellitus: molecular genetic analysis and family study. J. Neurol. Sci. 114:205-8
49. 49. Reardon W, Ross RJ, Sweeney MG, et al. 1992. Diabetes mellitus associated with a pathogenic point mutation in mitochondrial DNA. Lancet 340:1376-79
50. 50. Gerbitz KD, Paprotta A, Jaksch M, et al. 1993. Diabetes mellitus is one of the heterogeneous phenotypic features of a mitochondrial DNA point mutation within the tRNALeu(UUR) gene. FEBS Lett. 321: 194-96
51. 51. Kadowaki H, Tobe K, Mori Y, et al. 1993. Mitochondrial gene mutation and insulin-deficient type of diabetes mellitus. Lancet 341:893-94
52. 52. Anan R, Nakagawa M, Miyata M, et al. 1995. Cardiac involvement in mitochondrial diseases. A study on 17 patients with documented mitochondrial DNA defects. Circulation 91:955-61
53. 53. Schon EA, Bonilla E, DiMauro S. 1997. Mitochondrial DNA mutations and pathogenesis. J. Bioenerg, Biomemb. 29: 131-49
54. 54. Bardosi A, Creutzfeldt W, DiMauro S, et al. 1987. Myo-, neuro-, gastrointestinal encephalopathy (MNGIE syndrome) due to partial deficiency of cytochrome-c-oxidase. A new mitochondrial multisystem disorder. Acta Neuropathol. 74-. 248-58
55. 55. Hirano M, Silvestri G, Blake DM, et al. 1994. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical, biochemical, and genetic features of an autosomal recessive mitochondrial disorder. Neurology 44:721-27
56. 56. Barrett TG, Bundey SE. 1997. Wolfram (DIDMOAD) syndrome. J. Med. Genet. 34:838-41
57. 57. Jun AS, Brown MD, Wallace DC. 1994. A mitochondrial DNA mutation at nucleotide pair 14459 of the NADH dehydrogenase subunit 6 gene associated with maternally inherited Leber hereditary optic neuropathy and dystonia. Proc. Natl. Acad. Sci. USA 91:6206-10
58. 58. De Vries DD, Went LN, Bruyn GW, et al. 1996. Genetic and biochemical impairment of mitochondrial complex I activity in a family with Leber hereditary optic neuropathy and hereditary spastic dystonia. Am. J. Hum. Genet. 58:703-11
59. 59. Nelson I, Hanna MG, Alsanjari N, et al. 1995. A new mitochondrial DNA mutation associated with progressive dementia and chorea: a clinical, pathological, and molecular genetic study. Ann. Neurol. 37: 400-3
60. 60. Rotig A, De Lonlay P, Chretien D, et al. 1997. Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia. Nat. Genet. 17:215-17
61. 61. Dalakas MC, Illa I, Pezeshkpour GH, et al. 1990. Mitochondrial myopathy caused by long-term zidovudine therapy. N. Engl. J. Med 322:1098-105
62. 62. Frerman FE, Goodman SI. 1995. Nuclear-encoded defects of the mitochondrial respiratory chain, including glutaric acidemia type II. In The Metabolic and Molecular Basis of Inherited Diseases, ed. CR Scriver, WS Sly, D Valle, 1:1611-29. New York: McGraw-Hill
63. 63. Beal MF. 1995. Aging, energy, and oxidative stress in neurodegenerative diseases. Ann. Neurol. 38:357-66
64. 64. Eberling JL, Richardson BC, Reed BR, et al. 1994. Cortical glucose metabolism in Parkinson's disease without dementia. Neurobiol. Aging 15:329-35
65. 65. Bowen BC, Block RE, Sanchez-Ramos J, et al. 1995. Proton MR spectroscopy of the brain in 14 patients with Parkinson disease. Am. J. Neuroradiol. 16:61-68
66. 66. Schulz JB, Beal MF. 1994. Mitochondrial dysfunction in movement disorders. Curr. Opin. Neurol. 7:333
67. 67. Cortopassi G, Wang E. 1995. Modelling the effects of age-related mitochondrial DNA mutation accumulation; Complex I deficiency, Superoxide and cell death. Biochim. Biophys. Acta 1271:171-76
68. 68. Jenner P, Olanow CW. 1996. Oxidative stress and the pathogenesis of Parkinson's disease. Neurology 47:S161 (Suppl. 3)
69. 69. Langston JW. 1996. The etiology of Parkinson's disease with emphasis on the MPTP story. Neurology 47:S153-60
70. 70. Swerdlow RH, Parks JK, Miller SW, et al. 1996. Origin and functional consequences of the complex I defect in Parkinson's disease. Ann. Neurol. 40:663-71
71. 71. Bandmann O, Marsden CD, Wood NW. 1998. Genetic aspects of Parkinson's disease. Mov. Disord. 13:203-11
72. 72. Meccoci P, MacGarvey U, Beal MF. 1994. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann. Neurol. 36:747-51
73. 73. Hutchin TP, Heath PR, Pearson RCA, Sinclair AJ. 1997. Mitochondrial DNA mutations in Alzheimer's disease. Biochem. Biophys. Res. Commun. 241: 221-25
74. 74. Davis RE, Miller S, Herrnstadt C, et al. 1997. Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease. Proc. Natl. Acad. Sci. USA 94:4526-31
75. 75. Hirano M, Shtilbans A, Mayeux R, et al. 1997. Apparent mtDNA heteroplasmy in Alzheimer's disease patients and in normals due to PCR amplification of nucleus-embedded mtDNA pseudogenes. Proc. Natl. Acad Sci. USA 94: 14894-99
76. 76. Shigenega MK, Hagen TM, Ames BN. 1994. Oxidative damage and mitochondrial decay in aging. Proc. Natl. Acad. Sci. USA 91:10771-78
77. 77. Meccoci P, MacGarvey U, Kaufman AE, et al. 1993. Oxidative damage to mitochondria DNA shows marked age-dependent increases in human brain. Ann. Neurol. 34:609-16
78. 78. Cortopassi G, Shibata D, Soong N-W, Arnheim N. 1992. A pattern of accumulation of a somatic deletion of mtDNA in aging human tissues. Proc. Natl. Acad. Sci. USA 89:7370-74
79. 79. Siamonetta S, Chen X, DiMauro S, Schon EA. 1992. Accumulation of deletions in human mitochondrial DNA during normal aging: analysis by quantitative PCR. Biochim. Biophys. Acta 1180:113-22
80. 80. Shoffher JM. 1996. Maternal inheritance and the evaluation of oxidative phosphorylation diseases. Lancet 348:1283-88
81. 81. Rifai Z, Welle S, Kamp C, Thornton CA. 1995. Ragged red fibers in normal aging and inflammatory myopathy. Ann. Neurol. 37:24-29
82. 82. Fadic R, Johns DR. 1997. Treatment of mitochondrial encephalomyopathies. In Mitochondria and Free Radicals in Neurodegenerative Diseases, ed. MF Beal, N Howell, I Bodis-Wollner, pp. 537-55. New York: Wiley-Liss
83. 83. Crane FL, Navas P. 1997. The diversity of coenzyme Q function. Mol. Aspects Med. 18:S1 (Suppl.)
84. 84. Suno M, Nagoka A. 1984. Inhibition of lipid peroxidation by a novel compond (CV-2619) in brain mitochondria and mode of action of the inhibition. Biochem. Biophys. Res. Commun. 125:1046-52
85. 85. Miyamoto M, Coyle JT. 1990. Idebenone attenuates neuronal degeneration induced by intrastriatal injection of excitotoxins. Exp. Neurol. 108:38-45
86. 86. Beal MF, Henshaw R, Jenkins BG, et al. 1994. Coenzyme Q10 and nicotinamide block striatal lesions produced by the mitochondrial toxin malonate. Ann. Neurol. 36:882-86
87. 87. Whitehouse S, Cooper RH, Randle PJ. 1974. Mechanism of activation of pyruvate dehydrogenase by dichloracetate and other halogenated carboxylic acids. Biochem J. 141:761-74
88. 88. Matthews RT, Yang L, Jenkins BG, et al. 1998. Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington's disease. J. Neurosci. 18: 156-63
89. 89. Hagenfeldt L, von Doebeln U, Solders G, Kaijser L. 1994. Creatine treatment in MELAS. Muscle Nerve 17:1236-37
90. 90. Arts WF, Scholte HR, Bogaard JM, et al. 1983. NADH-CoQ reductase deficient myopathy: successful treatment with riboflavin. Lancet 2:581-82
91. 91. Halliwell B, Gutteridge JMC. 1985. Oxygen radicals and the nervous system. Trends Neurosci. 8:22-26
92. 92. Diaz MN, Frei B, Vita JA. 1997. Antioxidants and atherosclerotic heart disease. N. Engl. J. Med. 337:408-16
93. 93. Parkinson Study Group. 1993. Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease. N. Engl. J. Med. 328:176-83
94. 94. Pappert EJ, Tagney CC, Goetz CG, et al. 1996. Alpha-tocopherol in the ventricular cerebrospinal fluid of Parkinson's disease patients: dose-response study and correlations with plasma levels. Neurology 47: 1037-42
95. 95. Taylor RW, Chinnery PF, Turnbull DM, Lightowlers RN. 1997. Selective inhibition of mutant human mitochondrial DNA replication in vitro by peptide nucleic acids. Nat. Genet. 15:212-15
96. 96. Clark KM, Bindoff LA, Lightowlers RN, et al. 1997. Reversal of a mitochondrial DNA defect in human skeletal muscle. Nat. Genet. 16:222-2428